Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 1:43 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 337–360 of 620 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Diabetes Risk Clear all

Conditions: Type 2 Diabetes
Interventions: integrated program of nutrition, activity, behavior, and promotion; Behavioral
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 10 Years to 16 Years
Enrollment: 4,603 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2011
U.S. locations: 8
States / cities: Irvine, California • Rockville, Maryland • Chapel Hill, North Carolina + 5 more

Conditions: Metabolic Syndrome, Diabetes, Prediabetes, Hypertension
Interventions: Not listed
Lead sponsor: West Virginia School of Osteopathic Medicine; Other
Eligibility: 18 Years to 65 Years
Enrollment: 102 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Lewisburg, West Virginia

Conditions: Diabetes Mellitus
Interventions: Effect of Pulsatile IV insulin on diabetic pt blood markers, Effect of Pulsatile IV Insulin on blood markers; Procedure
Lead sponsor: Florida Atlantic University; Other
Eligibility: 21 Years to 85 Years
Enrollment: 105 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: Boca Raton, Florida

Conditions: Type 1 Diabetes, Celiac Disease
Interventions: Sera and whole blood sampling, Differential Gene Expression (DGE); Diagnostic Test
Lead sponsor: Sanford Health; Other
Eligibility: 0 Minutes to 17 Years
Enrollment: 33,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2031
U.S. locations: 4
States / cities: Bemidji, Minnesota • Bismarck, North Dakota • Fargo, North Dakota + 1 more

Conditions: Physical Inactivity, Cardiovascular Risk Factor, Obesity, Blood Pressure, PreDiabetes
Interventions: ActiveGOALSv2, PAT; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 40 Years to 70 Years
Enrollment: 54 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Accidental Falls, Fall Due to Loss of Equilibrium, High Risk of Falls Due to Mobility Limitation, Diabetes, Arthritis, Cancer, Peripheral Arterial Disease, Parkinson's Disease, End Stage Renal Failure on Dialysis
Interventions: MBB AFO, Control; Device · Other
Lead sponsor: Bijan Najafi, PhD; Other
Eligibility: 65 Years and older
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Stroke, Hypertension, Diabete Mellitus, Dyslipidemias, Sleep Disorder, Smoking, Overweight and Obesity, Familial Alzheimer Disease, Atrial Fibrillation, Cardiac Disease, Cognitive Impairment, Transient Ischemic Attack
Interventions: DELPhI system; Device
Lead sponsor: QuantalX Neuroscience; Industry
Eligibility: 50 Years to 75 Years
Enrollment: 335 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 3
States / cities: Walnut Creek, California • Atlanta, Georgia • Norwood, Ohio

Conditions: Diabetes, Prediabetic, Prediabetes, Glucose Intolerance
Interventions: eszopiclone; Drug
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years to 64 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2019
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Diabetes, Diet, Epidemiology, Stroke, Myocardial Infarction
Interventions: Not listed
Lead sponsor: University of Miami; Other
Eligibility: 40 Years and older
Enrollment: 3,497 participants
Timeline: 1993 – 2022
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Diabetes Prevention in Women After GDM Who Are at High-risk
Interventions: DAPA/MET XR, DAPA, MET XR; Drug
Lead sponsor: Woman's; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 69 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: PreDiabetes, Hyperglycemia, Glucose, High Blood, Overweight, Prediabetic State, Impaired Glucose Tolerance, Obesity, Weight Loss, Lifestyle, Healthy, Lifestyle Risk Reduction, Lifestyle, Sedentary
Interventions: Digital Diabetes Prevention Program (dDPP), Human Coach-based Diabetes Prevention Program (hDPP); Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 368 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 2
States / cities: Baltimore, Maryland • Reading, Pennsylvania

Conditions: Coronary Artery Disease, Atrial Fibrillation, Type 2 Diabetes, Colorectal Cancer, Breast Cancer, Prostate Cancer
Interventions: Polygenic risk score (PRS); Diagnostic Test
Lead sponsor: Boston VA Research Institute, Inc.; Other
Eligibility: 50 Years to 70 Years
Enrollment: 1,071 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Prediabetes
Interventions: FUERTE Arm, Standard care, No Intervention; Behavioral · Other
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years to 99 Years · Male only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: New York, New York

Conditions: Overweight and Obesity, PreDiabetes, Insulin Resistance
Interventions: CGM; Device
Lead sponsor: Mary Ellen Vajravelu, MD; Other
Eligibility: 8 Years to 18 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Insulin Resistance
Interventions: Novel dietary fiber, Placebo; Dietary Supplement · Other
Lead sponsor: Cargill; Industry
Eligibility: 30 Years to 70 Years
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Louisvile, Kentucky

Conditions: Diabetes Mellitus, Type 2, Prediabetic State, Hypertension, Prehypertension, Obesity
Interventions: FeatForward App (on study smartphone); Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 2
States / cities: Charlestown, Massachusetts • Revere, Massachusetts

Conditions: Pre Diabetic
Interventions: Fig, Control; Other
Lead sponsor: Clinical Nutrition Research Center, Illinois Institute of Technology; Industry
Eligibility: 30 Years to 50 Years · Female only
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Cardiovascular Diseases, Diabetes Mellitus, Medication Adherence
Interventions: Pharmacist-led, technology enabled education intervention; Behavioral
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Diabetes
Interventions: Intervention Phone Call; Behavioral
Lead sponsor: HealthPartners Institute; Other
Eligibility: 18 Years to 75 Years
Enrollment: 2,378 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Gestational Diabetes Mellitus (GDM), Metabolic Syndrome
Interventions: Semaglutide (Wegovy) weekly injection; Drug
Lead sponsor: University of Massachusetts, Worcester; Other
Eligibility: 18 Years and older · Female only
Enrollment: 226 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2030
U.S. locations: 1
States / cities: Worcester, Massachusetts

Conditions: Type 2 Diabetes, Healthy (Controls)
Interventions: Not applicable- observational study; Other
Lead sponsor: Guardian Research Network, Inc.; Other
Eligibility: 40 Years to 70 Years
Enrollment: 1,200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 2
States / cities: Orangeburg, South Carolina • Walhalla, South Carolina

Conditions: Diabetic Ulcer of Plantar Aspect of Left Foot, Diabetic Ulcer of Plantar Aspect of Right Foot, Diabetic Polyneuropathy
Interventions: nerve decompression; Procedure
Lead sponsor: Association of Extremity Nerve Surgeons; Other
Eligibility: 18 Years to 80 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 6
States / cities: Phoenix, Arizona • Scottsdale, Arizona • Tucson, Arizona + 3 more

Conditions: Diabetes Mellitus Type 2
Interventions: Not listed
Lead sponsor: Wyckoff Heights Medical Center; Other
Eligibility: 18 Years to 65 Years
Enrollment: 542 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Brooklyn, New York

Conditions: Diabetes, Dementia, Hypoglycemia; Drug
Interventions: STRIDE; Behavioral
Lead sponsor: Joslin Diabetes Center; Other
Eligibility: 18 Years and older
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Search by objective public record fields.

Middle-School Based Primary Prevention Trial of Type 2 Diabetes

Biomarkers of Metabolic Syndrome and Prediabetes

Effect of Pulsatile IV Insulin on Circulating Risk Markers of Vascular and Metabolic Complications in Pts With Diabetes

General Population Level Estimation for Type 1 Diabetes Risk in Children During Routine Care Delivery

The Clinical Referral to Activity Study

OHI--Randomized Control Trial to Evaluate Efficacy, Acceptability, and Perception of Benefit of an Innovative Custom AFO

DELPHI in Subjects at Risk for Stroke and Dementia

Sleep Effectiveness and Insulin and Glucose Homeostasis

Stroke Incidence and Risk Factors in a Tri-ethnic Region

Dapagliflozin and Metformin,Alone and in Combination, in Overweight/Obese Prior GDM Women

Effectiveness and Cost-Effectiveness of Fully-Automated Digital vs. Human Coach-Based Diabetes Prevention Programs

The Genomic Medicine at VA Study

Piloting FUERTE: Federally qUalified Health Centers Engaging Hispanic Men at Risk of diabeTEs

Continuous Glucose Monitors (CGM) for Type 2 Diabetes (T2D) Risk Evaluation

Effects of Novel Fiber on Glucose Metabolism and Insulin Sensitivity

Improving Physical Activity Through a mHealth Intervention in Cardio-metabolic Risk Patients

How Fig Polyphenols Affect Blood Sugar and Insulin Levels After Eating in Adults at Risk for Diabetes

Improving Medication Safety and CVD Risk Factor Control in Kidney Transplant Recipients

SUPREME-DM (Diabetes Mellitis) Treatment Study

Postpartum Semaglutide to Reduce Cardiometabolic Risk After Gestational Diabetes Mellitus

Specimen and Data Collection in South Carolina Medicaid-Enrolled Patients With Type 2 Diabetes (T2D) and Metabolically Healthy Controls

Nerve Decompression for Ulcer Recurrence Avoidance (DURA)

Rate of Change of HbA1c (dx/dt) May Predict Progression to Type 2 DM

Deprescribing of Diabetes Regimens in Long Term Care Residents With Alzheimer's